Stock SCPH SCPHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus scPharmaceuticals Inc.

Equities

SCPH

US8106481059

Real-time Estimate Cboe BZX
Other stock markets
 01:34:07 2024-04-29 pm EDT 		5-day change 1st Jan Change
4.52 USD +0.67% Intraday chart for scPharmaceuticals Inc. +0.11% -27.03%
Apr. 24 ScPharmaceuticals Inc. Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of Furoscix Auto-Injector (Furosemide 80Mg/Ml) Injection CI
Mar. 13 Transcript : ScPharmaceuticals Inc., Q4 2023 Earnings Call, Mar 13, 2024

Evolution of the average Target Price on scPharmaceuticals Inc.

Price target over the last 5 years

History of analyst recommendation changes

2bc9aee1da421bc20269c04ef957cd.PRTeX8_xxdpBijhm1gg4tVJUPXId4wlAt8gTyEBE1Wk.TXq8KZDAte106FswmW10hQgGdUQwj31wwOVp5Rch4F1kR5MUqcS1vi_LVw~4e46a302b1f579f0d133879be5eb3451

Analyst Recommendations on scPharmaceuticals Inc.

Craig-Hallum Starts scPharmaceuticals at Buy With $20 Price Target MT
Jefferies Adjusts scPharmaceuticals Price Target to $16 From $14, Maintains Buy Rating MT
Maxim Adjusts scPharmaceuticals' Price Target to $20 From $13, Keeps Buy Rating MT
SVB Securities Adjusts scPharmaceuticals Price Target to $13 From $12, Maintains Outperform Rating MT
Cowen Starts scPharmaceuticals at Outperform With $25 Price Target MT
SVB Securities Adjusts Price Target on scPharmaceuticals to $12 From $11, Maintains Outperform Rating MT
HC Wainwright Adjusts Price Target on scPharmaceuticals to $18 From $15, Maintains Buy Rating MT
Jefferies Assumes scPharmaceuticals at Buy with $14 Price Target MT
SVB Securities Upgrades scPharmaceuticals to Outperform From Market Perform, Adjusts Price Target to $11 From $6 MT
Maxim Initiates scPharmaceuticals at Buy, Sets $10 Price Target MT
SVB Securities Adjusts scPharmaceuticals' Price Target to $6 from $5, Keeps Market Perform Rating MT
SCPHARMACEUTICALS : SVB Leerink Starts scPharmaceuticals at Market Perform with $6 Price Target MT
SCPHARMACEUTICALS : SVB Leerink Adjusts ScPharmaceuticals' Price Target to $12 from $11, Keeps Market Perform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
4.49 USD
Average target price
19.5 USD
Spread / Average Target
+334.30%
High Price Target
25 USD
Spread / Highest target
+456.79%
Low Price Target
16 USD
Spread / Lowest Target
+256.35%

Consensus detail

Consensus revision (last 18 months)

Analysts covering scPharmaceuticals Inc.

Craig-Hallum
Jefferies & Co.
Maxim
SVB Securities LLC
Cowen
HC Wainwright
SVB Leerink

Ratings for scPharmaceuticals Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SCPH Stock
  4. Consensus scPharmaceuticals Inc.